Silver-Russell syndrome (SRS) is a heterogeneous disorder characterised by interauterine and postnatal growth retardation, with or without additional dysmorphic features. Most cases are sporadic but a few familial cases have been described. A subset of patients exhibit maternal uniparental disomy for chromosome 7 (mUPD7) strongly suggesting that genomic imprinting plays a role in the aetiology of the disease. We and others have recently characterised the human PEG1/MEST gene, the first imprinted gene known to be located on chromosome 7. Although the function of PEG1/MEST is unknown, the paternal-specific expression of this gene and its location at 7q32, render it a promising candidate for SRS. As a prerequisite for mutation screening in 49 patients with SRS and 9 with primordial growth retardation (PGR), we determined the complete genomic structure of the PEG1/MEST gene which consists of 12 exons. Apart from one silent mutation and two novel polymorphisms, nucleotide changes were not detected in any of these patients. Moreover, methylation patterns of the 5' region of PEG1/MEST were found to be normal in 35 SRS and 9 PGR patients and different from the pattern seen in patients with mUPD7. These findings strongly argue against a role of PEG1/MEST in the majority of Silver-Russell syndrome cases.
Introduction
Silver-Russell syndrome (SRS) is characterised by intrauterine as well as postnatal growth retardation. [1] [2] [3] Apart from PGR, most SRS patients have a triangular face, delayed bone maturation, hemihypertrophy and clinodactyly of the little fingers. Other less frequent anomalies are hypospadia, café-au-lait spots, syndactyly between the second and third toes, male hypoplasia and excessive sweating. None of these symptoms is obligatory, however; SRS patients may have PGR without any additional features. Most SRS cases are sporadic, but familial cases also exist. Both dominant and recessive inheritance have been reported. [4] [5] [6] The molecular basis of this disorder is unknown but its association with different chromosomal aberrations argues for genetic heterogeneity. In particular, two cases with severe SRS and balanced translocations disrupting the band 17q25, 7, 8 one girl with SRS and a ring chromosome 15 involving deletion of the IGF1R gene 9 and one patient with Silver-Russell syndrome-like features and an interstitial deletion of 8q11-q13 10 have been found. Moreover, numerous studies have shown that maternal UPD7 is associated with SRS or PGR, [11] [12] [13] [14] [15] [16] [17] whereas paternal UPD7 does not give rise to growth retardation. 18 Recently, we and others have isolated the imprinted human PEG1/MEST gene. 19, 20 The gene has been localised to chromosome 7q32 and in all foetal tissues the expression was confined to the paternal allele. 19 The precise function of PEG1/MEST is unknown although the presence of motifs found in alpha/beta-hydrolasefold enzymes points to a relationship with this family. Three strong lines of evidence have implicated PEG1/ MEST as a candidate gene for Silver-Russell syndrome. Firstly, PEG1/MEST is the first imprinted gene discovered to date which is located on chromosome 7. Secondly, its expression is confined to the paternally derived allele and therefore inactive in SRS patients with mUPD7. Thirdly, targeted inactivation of the paternally derived mouse Peg1/Mest allele results in viable but growth retarded embryos (L Lefebvre and MA Surani, personal communication).
In this study, we have screened 49 patients with SRS and 9 with PGR, all with confirmed biparental inheritance of chromosome 7, for mutations and methylation changes in the PEG1/MEST gene in an attempt to substantiate its role in these disorders.
Materials and Methods

Patients
DNA was extracted from blood samples as described by Miller et al. 21 Maternal UPD7 had been excluded for all patients by simple repeat analysis (own results, 15 . 
Genomic Structure of PEG1/MEST
Single Strand Conformation Analysis
The primers for PCR analysis were designed to cover the putative promoter region, all exons as well as the intron-exon boundaries of PEG1/MEST as outlined in Table 1 . For radioactive SSCP analysis the primers were endlabelled with T4 polynucleotide kinase (Gibco BRL) and [γ 32 P]ATP in 10 ϫ kinase buffer. PCR fragments were separated on 5% polyacrylamide-bisacrylamide (19:1) gels with and without 10% glycerol at 45 W, 4°C. Gels were transferred to filter paper, dried, and exposed to X-ray film for 10-24 h. Part of the exons were analysed by non-radioactive SSCP using the Multiphor II system (Pharmacia). 1-2 µl of PCR product was *Amplification of the 5' putative promoter region (#) and exon 1 was performed including 10% glycerol and 3.5% formamide. All primers are shown 5' to 3'. Exon 5 was amplified with two sets of forward primers, the first forward primer was identical to that of exon 4. The product from this reaction was used as template in the second PCR.
denatured in 95% formamide, 10 mM EDTA and loaded on an 8% polyacrylamide gel (29:1 or 49:1 acrylamide:bisacrylamide) containing 2% glycerol. Electrophoresis was performed for 3-4 h at 250 V, 15°C or 20°C in 1 ϫ TBE. For all exons resolution was optimised by applying both running conditions. Staining of the gels was performed according to standard technique.
Chromosome 7 Markers
Amplification of the dinucleotide repeats D7S2519 and D7S649 was performed with primer sets 5'-GGAGGTTAA-GATTTACAGACATG-3', 5'-TATCCTGTGTTTCCTTGTCCTG-3' and 5'-TGCTTTATTATGTCTGTTGTATG-3', 5'-ACTGAGT-CAAATTTGTAGAAGTT-3'. Thirty-five cycles of PCR consisted of denaturation at 94°C, 30 s, annealing at 56°C, 1 min, and elongation at 72°C, 1 min, in the presence of 1.5 mM MgCl 2 and [α 32 P]dCTP. Products were size-fractionated at 60 W for 3 h on standard 6.6% denaturing polyacrylamide gels. Exposure was for 24-48 h.
Methylation Analysis
For methylation analysis the DNAs were digested with (HindIII + HpaII) or (HindIII + MspI) and transferred onto GeneScreen Plus membrane exactly as described previously. 19 The 4.3 kb HindIII probe containing the 5' portion of the PEG1/MEST gene was labelled by random priming in the presence of [α 32 P]dCTP, and hybridisations were performed at 65°C. Washing was at hybridisation temperature in 2XSSC/ 0.1%SDS (2 ϫ 10 min) followed by 1XSSC/0.1%SDS for 15 min. Autoradiograms (Kodak X-omat) were exposed for 16 h to one week.
Results
Genomic Structure of PEG1/MEST
As a prerequisite for mutation screening in the PEG1/ MEST gene, we have first determined the complete exon-intron structure. Following subcloning of EcoRI fragments of the cosmid ICRFc113K246Q4, which had been isolated from a chromosome 7 specific library previously and had been shown to contain the entire gene,
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PEG1/MEST positive fragments were sequenced. Alignment of the genomic and cDNA sequences revealed that the PEG1/MEST gene contains 12 exons and encompasses a genomic region of approximately 13 kb. Exon-intron junctions are given in Table 2 and the structure of PEG1/MEST is shown schematically in Figure 1 .
Mutation Detection by Single Strand Conformation Polymorphism (SSCP)
SSCP analyses were performed to screen for mutations in the putative promoter region and all 12 exons of the PEG1/MEST gene. To include exon-intron junctions, primers were designed in the corresponding introns. In total, three bandshifts were detected, one in the putative promoter region and the others in exon 11 and 12, respectively. Sequencing of exon 11 and exon 12 fragments revealed a single nucleotide change T1065C, which is a silent mutation in exon 11 and a G1272C substitution which is located in the 3'UTR of the gene. The bandshift in the putative promoter region was present in the DNA of three patients and was also found in 15% of control DNAs. No other alterations were detected in the 58 patients tested.
In order to exclude the possibility of the patients being distantly related, we investigated two polymorphic CA-dinucleotide repeat markers, D7S2519 (accession No. Z54039 22 ) and D7S649 (accession No. Z23771, 23 ) which are located in the vicinity of the PEG1/MEST gene. 24 No evidence for allelic association 
Methylation Analysis in Silver-Russell Syndrome and Primordial Growth Retardation
To search for aberrant methylation patterns in the 5' CpG island of the PEG1/MEST gene resulting from 'imprinting mutations', we performed Southern blot hybridisations with DNA from SRS and PGR patients as target and a 4.3 kb HindIII fragment as probe. DNAs were digested with HindIII followed by digestion with either MspI or its methylation-sensitive isoschizomer HpaII. PEG1/MEST alleles derived from the mother give rise to a 4.3 kb fragment or to fragments of 4.3, 2.3 and 2 kb due to partial methylation of one MspI site in the vicinity of the CpG island. 19 Paternally-derived alleles are completely unmethylated and therefore digested by HpaII which is indicated by the presence of a 2.3 kb fragment and several smaller fragments. As shown in Figure 2 , all patients showed a methylation pattern identical to that of normal control DNA and different from the pattern observed in patients with mUPD7. This indicates that the paternal allele is not deleted and that both PEG1/MEST alleles exhibit normal parent-of-origin specific methylation patterns.
Discussion
Recently we have shown that the human PEG1/MEST gene is imprinted and expressed from the paternally derived allele. The gene has been mapped to chromosome 7q32. 19 The findings of Kotzot et al, 15 Preece et al 16 and Eggermann et al, 17 demonstrating that a subset of patients with SRS and primordial growth retardation carry two maternal chromosomes 7 while lacking the paternal counterpart, and the previously described association between mUPD7 and short stature, suggest that an imprinted gene on chromosome 7 is involved in this disorder. PEG1/MEST expression from the paternally-derived allele and its location on chromosome 7q, as well as the finding that in the mouse paternal inheritance of the inactivated Peg1/Mest allele leads to foetal growth retardation, renders it an excellent candidate gene for SRS.
In order to find mutations in the PEG1/MEST gene, we first determined the genomic structure which was found to consist of 12 exons. Mutation analysis by SSCP and subsequent sequencing revealed two novel polymorphisms and a single nucleotide change resulting in a silent mutation in exon 11. Very likely, none of these sequence variants is of functional importance and no other mutations were found. A monophyletic origin of the SRS patients is most unlikely since no evidence for allelic association could be obtained by analysing two highly polymorphic microsatellites which are located in the vicinity of PEG1/MEST.
Silver-Russell syndrome patients with mUPD7 lack the paternally expressed PEG1/MEST gene product. Silencing of the maternally derived PEG1/MEST allele is reflected by maternal-specific methylation of the CpG island at the 5' portion of the gene. During gametogenesis, parental-specific (methylation) marks have to be reset according to the gender of the individual. In a minority of cases this resetting fails, resulting in an incorrect parental methylation profile. Such so-called 'imprinting mutations' have been identified in patients with imprinted gene disorders such as Prader-Willi syndrome (PWS), Angelman syndrome (AS) and Beckwith-Wiedemann syndrome. 25, 26 In PWS and AS the imprinting mutations arise in the imprinting center which regulates imprinted gene expression and methylation over a distance of several hundred kilobases. 27 In this region, tissue-specific imprinting for UBE3A has been observed with expression from the maternally-derived allele in the brain, but biallelic expression in other foetal tissues and adult lymphocytes and fibroblasts. 28, 29 The PEG1/MEST gene is also biallelically expressed in adult blood cells but parentspecific methylation differences are still present. In all SRS patients tested, analysis of the critical 5' region of the PEG1/MEST gene revealed methylation patterns identical to that of normal control DNAs. These findings rule out silencing of PEG1/MEST in the SRS by aberrant methylation of the putative promoter region caused by 'imprinting mutations'. Taken together, the absence of mutations in the PEG1/MEST putative promoter region and the entire coding region including exon/intron boundaries and the normal methylation patterns of the 5' CpG island, strongly argue against an involvement of the PEG1/MEST gene in the majority of SRS cases. We cannot, however, product and disruption of the paternal allele is suspected to have a negative effect on growth as deduced from the gene targetting experiments in mice. Since SRS is heterogeneous, mutations in any of the genes could be present in a relatively small number of SRS cases. In mice, maternal duplication of the proximal region of chromosome 6, including Peg1/Mest leads to embryonic lethality, whereas paternal duplication of this region is viable. 30 It is not yet understood why mice with maternal disomy for this region die in embryogenesis whereas in humans mUPD7 is associated with a relatively mild phenotype. The leaky expression of the maternal PEG1/MEST gene observed in humans but not in the mouse could be sufficient to avoid embryonic lethality. 20, 31 In mice, imprinting and X-inactivation processes are, in general, more strictly regulated than in humans which might explain the more severe problems observed on parent-specific duplications of imprinted regions.
Imprinted genes tend to be clustered, as documented for the human and mouse genome. In humans, two major clusters, one on chromosome 15q11-q13 and the other on chromosome 11p15.5, have been identified. It is therefore tempting to speculate that apart from PEG1/MEST, the relevant region on chromosome 7 harbours additional imprinted genes, one of which may be involved in SRS and/or primordial growth retardation. The imprinting status of expressed sequences from this region is currently being investigated.
